Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives
Open Access
- 1 January 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 32 (1) , 885-892
Abstract
A series of new derivatives was prepared by derivatisation of the 7-amino moiety present in 7-amino-3,4-dihydroquinolin-2(1H)-one, a compound investigated earlier as CAI. The derivatisation was achieved by: i) reaction with arylsulfonyl isocyanates/aryl isocyanates; (ii) reaction with fluorescein isothiocyanate; (iii) condensation with substituted benzoic acids in the presence of carbodiimides; (iv) reaction with 2,4,6-trimethyl-pyrylium tetrafluoroborate; (v) reaction with methylsulfonyl chloride and (vi) reaction with maleic anhydride. The new compounds were assayed as inhibitors of four carbonic anhydrases (CA, EC 4.2.1.1) human (h) isoforms of pharmacologic relevance, the cytosolic hCA I and II, the membrane-anchored hCA IV and the transmembrane, tumour-associated hCA IX. hCA IX was the most inhibited isoform (KIs ranging between 243.6 and 2785.6 nm) whereas hCA IV was not inhibited by these compounds. Most derivatives were weak hCA I and II inhibitors, with few of them showing KIs < 10 µm. Considering that the inhibition mechanism with these lactams is not yet elucidated, exploring a range of such derivatives with various substitution patterns may be useful to identify leads showing isoform selectivity or the desired pharmacologic action.Keywords
This publication has 60 references indexed in Scilit:
- Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 captureJournal of Enzyme Inhibition and Medicinal Chemistry, 2013
- Structure-based drug discovery of carbonic anhydrase inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in VivoJournal of Medicinal Chemistry, 2012
- A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacologyJournal of Enzyme Inhibition and Medicinal Chemistry, 2011
- Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studiesBioorganic & Medicinal Chemistry, 2011
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX InhibitorsCancer Research, 2011
- Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?Frontiers in Pharmacology, 2011
- Carbonic anhydrase inhibitorsBioorganic & Medicinal Chemistry Letters, 2010
- Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moietiesBioorganic & Medicinal Chemistry Letters, 2004
- Unsymmetrical 1,1′-disubstituted Ferrocenes: Synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) Chelates of Ferrocenyl -1-thiadiazolo-1′-tetrazole, -1-thiadiazolo-1′-triazole and -1-tetrazolo-1′-triazole with Antimicrobial PropertiesJournal of Enzyme Inhibition and Medicinal Chemistry, 2002